Monday, September 19th, 2011, 6:00 PM
At Women in Leadership club’s inaugural conference, the MBA HEC students were honoured to have Mrs. Sabine Dandiguian as guest speaker. Mrs. Dandiguian is Managing Director, Emerging Markets, Janssen EMEA, Johnson & Johnson group and former President of Janssen France and Janssen Belgium.
A noble topic: “LIFE”
Before the conference, we were excited about what we believed would be an opportunity to learn more about pharmaceutical industry economic model and the ongoing changes in markets.
Mrs. Dandiguian sent us a very inspiring message about how much Janssen enriches its employees and the communities around the world. She said that, despite of some rumours (that are circulating) about the pharmaceutical industry; the aim of the industry is a noble topic: “LIFE”.
Markets and Challenges: yesterday, today, tomorrow
Mrs. Dandiguian said that the changing structure of the pharmaceutical industry is driven by several factors: patent expiration for blockbuster drugs, healthcare budget deficit, cost and price evolution, increase demand in regulation & transparency, R&D productivity and accessibility.
On the innovation side, our speaker said that the “integrate information” will play a major role in a better diagnosis and an accelerate access to the treatments. Patients, hospitals, physicians and pharmacies will be more and more connected through Internet.
Nevertheless, Janssen wants to “reach the best of science” by building bridges between biotech, biomarkers and pharmaceutical companies, academic, patients associations.
We had also an interesting benchmark presentation on the economic business models of some important Johnson & Johnson competitors.
Leadership and Diversity at Johnson & Johnson
The empowerment of the local teams by decentralisation, the right people in the right country/market, the collaborative taking decision style, the self awareness and adaptability are some of the Johnson & Johnson corporate values and drivers for excellence that Mrs. Dandiguian shared with us.
The diversity of origins/culture, thoughts, gender exists at all the levels in the company, said Mrs. Dandiguian.
At the end of the conference, as a conclusion Mrs. Dandiguian accentuated how important is the credo at Johnson & Johnson and how the credo embraces all the values of the company and is anchored very deep in all the processes and interactions, either internally or externally.
Bianca Roatis, Part-Time MBA 2012
“I spent a very good moment to this conference. The speaker was a charismatic person, who gave us a lot of key information helping us to understand better Janssen strategies in emerging markets. Despite some recent debates in France about this subject, we could put some open questions about the pharmaceutical sector, too. This was the first time that I attended a WiL conference and what is sure is that… I will attend as much as I can to those conferences, thanks!”
Linda Goumara, Part-Time MBA 2012
“What I really enjoyed during the conference was the finest analysis presented by Mrs. Dandiguian about the changes and challenges that the pharmaceutical industry faces and will faces during the next decade. I discover a very dynamic industry beside the constraints: regulatory, cost, social/cultural, etc. It was interesting to see how the business development strategy in emerging markets fits with the HR & Diversity strategy and with the Johnson & Johnson corporate values. Furthermore, the communication talent of our speaker contributed to facilitate the highly appreciated interaction with the audience. Thank you to the Johnson & Johnson team (Mrs. Muriel Malbezin – Vice president Medical Affairs and Mrs. Maryse Veysseyre-Smol – Executive Assistant to MD & HRD) for this opportunity to interact and learn from the unique experiences of Mrs. Dandiguian.
Bianca Roatis, Part-Time MBA 2012
Special thanks to the organizers for putting the events together:
- Bianca Roatis, President
- Blanca Edigo-De-Miguel, Vice-President
- Mariana DOMINGUEZ-SALAS, Corporate Relations Director